Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial
CVS Caremark faces class-action lawsuit over Zepbound, Wegovy coverage CVS Caremark is facing a class-action lawsuit over its decision to stop covering Zepbound, Eli Lillys blockbuster GLP-1 weight-loss drug
A heart-healthy diet remains the best option for cardiac health. Cardiac rehab educates and empowers patients As heart diagnostics and treatments become more personalized to patients genetics, medical histories and lifestyles, so does the preventive care provided to cardiac patients
It is temporary and can be managed by staying well hydrated, maintaining oral hygiene, eating balanced meals, and following a gut-friendly diet
Some research suggests that GLP-1 agonists may interact with serotonin pathways, increasing activity at certain serotonin receptors, particularly 5-HT2C
Behavioral relapse prevention plans are particularly effective